Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op. Grant: NWHRI: Innovation Fund - Translational Research

University of British Columbia

$495,144.00

Development and validation of a clinical assessment tool to improve detection of brain injury in intimate partner violence

FY 2023-24

Summary
Intimate partner violence (IPV) is disturbingly common with a recent Statistics Canada report estimating that 44% of Canadian women have experienced it in their lifetime. Approximately 30% of women who have survived IPV report impacts to the head and face, and non-fatal strangulation - injury mechanisms that have the potential to result in brain injury (BI). Although a number of tools are available for screening potential BI in IPV, they are not designed for clinical decision-making. In order to provide timely and appropriate treatment and support for women who have experienced IPV, it is crucial to detect potential BI as early as possible. Therefore, the proposed work aims to develop a valid and reliable tool that is quick and simple to use and detects whether a BI from IPV has occurred or not. Such a tool should include key questions about the injury mechanisms (e.g., punching, hitting, slapping, non-fatal strangulation, etc.) and BI signs and symptoms (e.g., loss or alteration in consciousness, post-traumatic amnesia, dizziness, memory loss etc.). To determine the sensitivity and specificity of the different questions, they will be compared to blood biomarkers for BI that are being collected at several recruitment sites as part of a related project. This information will be used to to determine the number and content of questions needed to accurately detect whether a BI has occurred or not. As part of this process, Principal Knowledge User Ehirchiou along with the other clinical collaborators on the team will be embedded in the development and refinement of the tool with a particular focus on the ease and feasibility of use. In addition, advice and feedback from the patient perspective will be sought from an advisory panel of women all of whom have lived experience of IPV-BI. As a result of the proposed work, a valid and reliable tool to detect BI from IPV will be available for clinical decision-making.
Program
Op. Grant: NWHRI: Innovation Fund - Translational Research
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
505352
Name
van Donkelaar Paul
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
National Women's Health Research Initiative: Innovation Fund
Projecttitle
Development and validation of a clinical assessment tool to improve detection of brain injury in intimate partner violence
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$495,144
Cihrequipment2
$0
Programname2
Op. Grant: NWHRI: Innovation Fund - Translational Research
Keyworddelim
Blood Biomarkers; Brain Injury; Intimate Partner Violence; Non-Fatal Strangulation
Abstract
Intimate partner violence (IPV) is disturbingly common with a recent Statistics Canada report estimating that 44% of Canadian women have experienced it in their lifetime. Approximately 30% of women who have survived IPV report impacts to the head and face, and non-fatal strangulation - injury mechanisms that have the potential to result in brain injury (BI). Although a number of tools are available for screening potential BI in IPV, they are not designed for clinical decision-making. In order to provide timely and appropriate treatment and support for women who have experienced IPV, it is crucial to detect potential BI as early as possible. Therefore, the proposed work aims to develop a valid and reliable tool that is quick and simple to use and detects whether a BI from IPV has occurred or not. Such a tool should include key questions about the injury mechanisms (e.g., punching, hitting, slapping, non-fatal strangulation, etc.) and BI signs and symptoms (e.g., loss or alteration in consciousness, post-traumatic amnesia, dizziness, memory loss etc.). To determine the sensitivity and specificity of the different questions, they will be compared to blood biomarkers for BI that are being collected at several recruitment sites as part of a related project. This information will be used to to determine the number and content of questions needed to accurately detect whether a BI has occurred or not. As part of this process, Principal Knowledge User Ehirchiou along with the other clinical collaborators on the team will be embedded in the development and refinement of the tool with a particular focus on the ease and feasibility of use. In addition, advice and feedback from the patient perspective will be sought from an advisory panel of women all of whom have lived experience of IPV-BI. As a result of the proposed work, a valid and reliable tool to detect BI from IPV will be available for clinical decision-making.
Competitiondate
202403
Approvedterm2
2 yrs 10 mths
Pinamesdelim
van Donkelaar, Paul; Ehirchiou, Jennifer L
Approvedterm
2 ans 10 mois
Cihrcontribution2
IGH~ $203,333~ $0~MI #4~ $291,811~ $0~